OxiGene (OXGN)

Add to Watchlists Create an Alert
2.46 -0.03  -1.20% NASDAQ Jul 25, 8:00PM BATS Real time Currency in USD
View Full Chart
OXGN Price Chart
View All Events

OXGN Events

Date Type Description
06/10/2014 Misc Annual General Meeting for OxiGene Inc
05/06/2014 16:30 EDT Misc OxiGene Inc Q1 2014 Earnings Conference Call
05/06/2014 Earnings OxiGene Inc Q1 2014 Earnings Results.
03/18/2014 16:30 EDT Misc OxiGene, Inc. Q4 2013 Earnings Conference Call
03/18/2014 Earnings OxiGene, Inc. Q4 2013 Earnings Results.
11/12/2013 16:00 EDT Misc Oxigene Announces Third Quarter 2013 Earnings Conference Call and Webcast
11/12/2013 Earnings Third Quarter 2013 Financial Results.
08/06/2013 04:30 EDT Misc Oxigene Announces Second Quarter 2013 Earnings Conference Call and Webcast
08/06/2013 Earnings Second Quarter 2013 Financial Results.
View All Performance Charts

OXGN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). OxiGene is down 10.87% over the last year vs S&P 500 Total Return up 19.50%, Achillion Pharmaceuticals up 0.14%, and InterMune up 208.3%.

Get Quote for

Portfolio Strategies Featuring OXGN

Did OxiGene make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

OXGN Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.oxigene.com
  • IR Website: http://investor.oxigene.com/
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: March 31, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

OxiGene, Inc., is a biopharmaceutical company. It is engaged in development of vascular disrupting agents (VDAs) for the treatment of cancer.

OXGN Excel Add-In Codes

  • Name: =YCI("OXGN","name")
  • Description: =YCI("OXGN","description")
  • Sector: =YCI("OXGN","sector")
  • Industry: =YCI("OXGN","industry")
  • Est. Current Fiscal Year End: =YCI("OXGN","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership


{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.